<SEC-DOCUMENT>0001104659-25-100321-index.html : 20251017
<SEC-HEADER>0001104659-25-100321.hdr.sgml : 20251017
<ACCEPTANCE-DATETIME>20251017120241
ACCESSION NUMBER:		0001104659-25-100321
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20251017
DATE AS OF CHANGE:		20251017

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LAVA Therapeutics NV
		CENTRAL INDEX KEY:			0001840748
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40241
		FILM NUMBER:		251399403

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		YALELAAN 62
		CITY:			UTRECHT
		PROVINCE COUNTRY:   	P7
		BUSINESS PHONE:		31 6 3000 3035

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		YALELAAN 62
		CITY:			UTRECHT
		PROVINCE COUNTRY:   	P7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LAVA Therapeutics BV
		DATE OF NAME CHANGE:	20210115
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>tm2528774d2_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: tm2528774d2_defa14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>tm2528774d2_ex2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
Document 2 - file: tm2528774d2_ex2-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tm2528774d2_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 3 - file: tm2528774d2_ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm2528774d1_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: tm2528774d1_ex99-1img01.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2528774d1_ex99-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: tm2528774d1_ex99-1img02.jpg

</DOCUMENT>
</SEC-DOCUMENT>